SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES
    7.
    发明申请
    SYNTHESIS OF MSE-FRAMEWORK TYPE MOLECULAR SIEVES 有权
    MSE-FRAMEWORK型分子筛的合成

    公开(公告)号:US20140140921A1

    公开(公告)日:2014-05-22

    申请号:US14054038

    申请日:2013-10-15

    IPC分类号: B01J29/70

    CPC分类号: B01J29/70 C01B39/04 C01B39/48

    摘要: An aspect of the invention relates to a method of synthesizing a crystalline molecular sieve having an MSE framework type, the method comprising crystallizing a reaction mixture comprising a source of water, a source of an oxide of a tetravalent element, Y, selected from at least one of silicon, tin, titanium, vanadium, and germanium, optionally but preferably a source of a trivalent element, X, a source of an alkali or alkaline earth metal, M, a source of a tetraethylammonium cation, Q1, and optionally a source of a second organic cation, Q2, which can include a cyclic nitrogen-containing ammonium cation.

    摘要翻译: 本发明的一个方面涉及一种合成具有MSE骨架类型的结晶分子筛的方法,所述方法包括使包含水源的反应混合物,四价元素的氧化物源Y至少结晶,所述Y选自至少 硅,锡,钛,钒和锗中的一种,任选但优选为三价元素的源X,碱金属或碱土金属的源,M,四乙基铵阳离子源,Q1和任选的源 的第二有机阳离子Q2可以包括环状含氮铵阳离子。

    Treatment of cold start engine exhaust
    9.
    发明授权
    Treatment of cold start engine exhaust 有权
    冷启动发动机排气处理

    公开(公告)号:US08580228B2

    公开(公告)日:2013-11-12

    申请号:US11961776

    申请日:2007-12-20

    摘要: The present invention relates to a process for reducing cold start emissions in an exhaust gas stream (such as from an internal combustion engine) by contacting the exhaust stream with a combination of molecular sieves comprising (1) a small pore crystalline molecular sieve or mixture of molecular sieves having pores no larger than 8 membered rings selected from the group consisting of SSZ-13, SSZ-16, SSZ-36, SSZ-39, SSZ-50, SSZ-52 and SSZ-73 molecular sieve and having a mole ratio at least 10 of (a) an oxide of a first tetravalent element to (b) an oxide of a trivalent element, pentavalent element, second tetravalent element which is different from said first tetravalent element or mixture thereof and (2) a medium-large pore crystalline molecular sieve having pores at least as large as 10 membered rings selected from the group consisting of SSZ-26, SSZ-33, SSZ-64, zeolite Beta, CIT-1, CIT-6 and ITQ-4 and having a mole ratio of at least 10 of (a) an oxide of a first tetravalent element to (b) an oxide of a trivalent element, pentavalent element, second tetravalent element which is different from said first tetravalent element or mixture thereof.

    摘要翻译: 本发明涉及通过使废气流与分子筛的组合接触来减少废气流(例如来自内燃机)中的冷启动排放的方法,所述分子筛包括(1)小孔结晶分子筛或 具有不大于8元环的分子筛,其选自SSZ-13,SSZ-16,SSZ-36,SSZ-39,SSZ-50,SSZ-52和SSZ-73分子筛,并且具有摩尔比 至少10个(a)第一四价元素的氧化物,(b)三价元素的氧化物,不同于所述第一四价元素或其混合物的五价元素,第二四价元素和(2)中等大小 孔结晶分子筛,其孔至少与选自SSZ-26,SSZ-33,SSZ-64,β沸石,CIT-1,CIT-6和ITQ-4组成的组中的10元环一样大,并具有摩尔 (a)第一四价元素的氧化物的至少10的比例 至(b)不同于所述第一四价元素或其混合物的三价元素的氧化物,五价元素,第二四价元素。

    VOLATILE ANESTHETIC COMPOSITIONS COMPRISING EXTRACTIVE SOLVENTS FOR REGIONAL ANESTHESIA AND/OR PAIN RELIEF
    10.
    发明申请
    VOLATILE ANESTHETIC COMPOSITIONS COMPRISING EXTRACTIVE SOLVENTS FOR REGIONAL ANESTHESIA AND/OR PAIN RELIEF 有权
    包含用于区域性麻醉和/或疼痛缓解的提取溶剂的挥发性麻醉组合物

    公开(公告)号:US20110039944A1

    公开(公告)日:2011-02-17

    申请号:US12863755

    申请日:2009-01-22

    IPC分类号: A61K31/08 A61P39/02

    摘要: The present invention provides methods for reducing pain in a subject in need of such pain reduction by delivering, e.g., intrathecally or epidurally, a volatile anesthetic dissolved in a solution comprising an extractive solvent, e.g., DMSO or NMP, in an amount effective to reduce pain. Chronic or acute pain may be treated, or the anesthetic may be delivered as a regional anesthesia to a subject to anesthetize a portion the subject prior to a surgery, hi certain embodiments, isoflurane, halothane, enflurane, sevoflurane, desflurane, methoxyflurane, or mixtures thereof may be used. Dosing regimens including a one-time administration, continuous and/or periodic administration are contemplated.

    摘要翻译: 本发明提供了通过递送(例如)鞘内或硬膜外地溶解在包含萃取溶剂(例如DMSO或NMP)的溶液中的挥发性麻醉剂来减少需要这种疼痛减轻的受试者的疼痛的方法,其量有效降低 疼痛。 可以治疗慢性或急性疼痛,或者麻醉剂可以作为局部麻醉递送给受试者,以在手术之前麻醉受试者的一部分。在某些实施方案中,异氟烷,氟烷,恩氟烷,七氟醚,地氟烷,甲氧氟烷或其混合物 可以使用。 预期包括一次给药,连续和/或定期给药的给药方案。